Research location
Hildesheim
Lower Saxony, Germany
Advertisement
Research activity in Hildesheim
Lower Saxony, GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 30 trials and 31 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hildesheim
30 linked trials · page 1 of 1A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of RecurrenceNCT06830720 · 2025-02-20 · 1 site observation
RECRUITING
NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)NCT06081244 · 2024-10-10 · 1 site observation
RECRUITING
Phase IIIb Study of Ribociclib + ET in Early Breast CancerNCT05827081 · 2024-02-28 · 1 site observation
RECRUITING
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast CancerNCT05704829 · 2024-02-05 · 1 site observation
RECRUITING
PROCARE - PROstate Cancer Real World Evidence RegistryNCT06835218 · 2024-01-29 · 2 site observations
RECRUITING
PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFSNCT05792150 · 2022-12-07 · 1 site observation
RECRUITING
NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast CancerNCT07178730 · 2026-08-30 · 1 site observation
NOT_YET_RECRUITING
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast CancerNCT04495309 · 2021-03-05 · 1 site observation
COMPLETED
Real-life Pan-HER-blockade With NeratinibNCT04388384 · 2020-07-02 · 1 site observation
COMPLETED
Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBCNCT04055493 · 2019-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentNCT06311383 · 2017-10-09 · 1 site observation
COMPLETED
Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to InfliximabNCT02937701 · 2016-10-10 · 1 site observation
COMPLETED
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination DeficiencyNCT02789332 · 2016-09-01 · 1 site observation
COMPLETED
Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltrationNCT02769351 · 2015-12-03 · 1 site observation
TERMINATED
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary SurgeryNCT02466737 · 2015-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®NCT02514772 · 2015-07-01 · 1 site observation
COMPLETED
BIBW 2992 (Afatinib) and VinorelbineNCT01531764 · 2012-07-01 · 1 site observation
TERMINATED
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.NCT00770653 · 2007-04-01 · 1 site observation
COMPLETED
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)NCT00500331 · 2007-01-23 · 1 site observation
COMPLETED
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseNCT00348309 · 2006-07-06 · 1 site observation
COMPLETED
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson'sNCT00331149 · 2006-06-20 · 1 site observation
COMPLETED
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs SyndromeNCT00357097 · 2006-06-01 · 1 site observation
COMPLETED
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid ArthritisNCT00134693 · 2005-06-21 · 1 site observation
COMPLETED
COX-2 Inhibitor Study In Patients With Rheumatoid ArthritisNCT00113308 · 2005-06-01 · 1 site observation
COMPLETED
Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant ChemotherapyNCT00512993 · 2004-12-01 · 1 site observation
COMPLETED
Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.NCT00069836 · 2003-10-01 · 1 site observation
COMPLETED
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskNCT00056407 · 2003-03-01 · 1 site observation
COMPLETED
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideNCT00279045 · 2000-01-03 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.